Latest Feature

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Kona Medical launches hypertension trial for non-invasive RDN device

August 29, 2014 by Brad Perriello

Kona Medical announces the launch of a clinical trial for its non-invasive Surround Sound renal denervation device for treating hypertension.

Kona Medical launches hypertension trial for non-invasive RDN device

Kona Medical said this week that it's launched a clinical trial of the non-invasive renal denervation device for treating hypertension it calls Surround Sound.

MassDevice.com +3 | The top 3 medtech stories for August 29, 2014

August 29, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Report: Boston Scientific wins 2nd pelvic mesh bellwether

August 29, 2014 by Brad Perriello

Boston Scientific reportedly wins the 2nd bellwether trial over its Obtryx pelvic mesh device, a month after winning the 1st personal injury case to go to trial over its transvaginal sling devices.

Report: Boston Scientific wins 2nd pelvic mesh bellwether

Bay State Democrats spar over the medical device tax in 6th district congressional race

August 29, 2014 by Arezu Sarvestani

Massachusetts Congressional challenger Seth Moulton vows to fight against the medical device tax, putting fellow Democrat and long-time House incumbent John Tierney on blast.

Bay State Democrats spar over the medical device tax

The medical device tax has long been a rallying point for lawmakers on the right, but the levy is making a cameo appearance in a fight among Democrats looking to represent Massachusetts' 6th District.

Report: J&J puts Cordis on the block

August 29, 2014 by Arezu Sarvestani

Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.

Report: J&J's selling its Cordis division

Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.

Arthrex wins $255M Defense Dept. contract

August 29, 2014 by Brad Perriello

Arthrex outbids nearly 60 competitors to win a contract with the U.S. Defense Dept. that's worth $255 million.

Arthrex wins $255M Defense Dept. contract

Arthrex won a Pentagon contract worth $255 million, beating out nearly 60 other bidders for the deal, the U.S. Defense Dept. said yesterday.

The 5-year base contract for "medical items and accessories" went through a competitive bidding process that included bids from 57 other companies, the Pentagon said.

Baxter says HQ will stay in Illinois, stays coy on Boston plans

August 29, 2014 by Brad Perriello

Baxter International says it will keep its headquarters in Illinois, despite recent reports of a possible move to Boston, but stays coy on its actual plans in The Hub.

Baxter says HQ will stay in Illinois, stays coy on Boston plans

Medtronic to cover $58M tax tab for top execs in Covidien buy

August 29, 2014 by Brad Perriello

Medtronic reveals that the tax tab for its top executives from its Covidien buyout will near $58 million, apart from the capital gains taxes all shareholders will pay on the $43 billion deal.

Medtronic to cover $58M tax tab for top execs in Covidien buy
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp